Literature DB >> 20827386

Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma.

Kunal Gangwal1, Devin Close, Camille A Enriquez, Christopher P Hill, Stephen L Lessnick.   

Abstract

ETS proteins are a family of transcription factors that play important roles in the development of cancer. The Ewing's sarcoma EWS/ETS fusion oncoproteins control a number of cancer-relevant phenotypes in that disease. We recently demonstrated that EWS/FLI, the most common EWS/ETS fusion in Ewing's sarcoma, regulates a portion of its target genes, including the critical target NR0B1, via GGAA-containing microsatellites in their promoters. Given the unusual nature of microsatellites as EWS/FLI response elements, we sought to elucidate the mechanism of EWS/FLI activity at these sites. We found that the ability to bind GGAA microsatellites is shared by multiple ETS family members from distinct phylogenetic subfamilies. Importantly, however, only EWS/ETS-containing fusions are capable of mediating transcriptional activation via these elements, highlighting a neomorphic function of the Ewing's sarcoma fusion proteins. Additional analysis revealed that the GGAA microsatellite binds EWS/FLI with an affinity that is 2 to 3 orders of magnitude lower than previously identified high-affinity consensus/redundant binding sites. The stoichiometry of this interaction is 2 protein molecules for each DNA molecule, suggesting that EWS/FLI binds these elements as a homodimer. The isolated FLI ETS domain bound microsatellite sequences in a nearly identical fashion to full-length EWS/FLI, thus indicating that residues required for homodimeric binding are localized to the ETS domain. These data suggest a new paradigm for an ETS family member binding to DNA at cancer-relevant genetic loci and highlight emergent properties of EWS/FLI that are required for the development of Ewing's sarcoma.

Entities:  

Year:  2010        PMID: 20827386      PMCID: PMC2935179          DOI: 10.1177/1947601910361495

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  45 in total

1.  DNA binding specificity studies of four ETS proteins support an indirect read-out mechanism of protein-DNA recognition.

Authors:  B R Szymczyna; C H Arrowsmith
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

2.  Structural studies of Ets-1/Pax5 complex formation on DNA.

Authors:  C W Garvie; J Hagman; C Wolberger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 3.  Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.

Authors:  Leah A Owen; Stephen L Lessnick
Journal:  Cell Cycle       Date:  2006-09-15       Impact factor: 4.534

4.  Applications of fluorescence anisotropy to the study of protein-DNA interactions.

Authors:  Vince J LiCata; Andy J Wowor
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

5.  Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.

Authors:  J A Nye; J M Petersen; C V Gunther; M D Jonsen; B J Graves
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

6.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma.

Authors:  F Urano; A Umezawa; W Hong; H Kikuchi; J Hata
Journal:  Biochem Biophys Res Commun       Date:  1996-02-15       Impact factor: 3.575

7.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Authors:  I S Jeon; J N Davis; B S Braun; J E Sublett; M F Roussel; C T Denny; D N Shapiro
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

8.  EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.

Authors:  Michelle Kinsey; Richard Smith; Anita K Iyer; Edward R B McCabe; Stephen L Lessnick
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

9.  Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy.

Authors:  Y Kaneko; K Yoshida; M Handa; Y Toyoda; H Nishihira; Y Tanaka; Y Sasaki; S Ishida; F Higashino; K Fujinaga
Journal:  Genes Chromosomes Cancer       Date:  1996-02       Impact factor: 5.006

10.  The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function.

Authors:  Noëlle Guillon; Franck Tirode; Valentina Boeva; Andrei Zynovyev; Emmanuel Barillot; Olivier Delattre
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

View more
  32 in total

1.  [Integrative molecular pathology of cancer].

Authors:  Thomas G P Grünewald
Journal:  Pathologe       Date:  2020-12       Impact factor: 1.011

Review 2.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

3.  EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.

Authors:  Nicolò Riggi; Birgit Knoechel; Shawn M Gillespie; Bradley E Bernstein; Miguel N Rivera; Esther Rheinbay; Gaylor Boulay; Mario L Suvà; Nikki E Rossetti; Wannaporn E Boonseng; Ozgur Oksuz; Edward B Cook; Aurélie Formey; Anoop Patel; Melissa Gymrek; Vishal Thapar; Vikram Deshpande; David T Ting; Francis J Hornicek; G Petur Nielsen; Ivan Stamenkovic; Martin J Aryee
Journal:  Cancer Cell       Date:  2014-10-30       Impact factor: 31.743

4.  Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth.

Authors:  Kirsten M Johnson; Nathan R Mahler; Ranajeet S Saund; Emily R Theisen; Cenny Taslim; Nathan W Callender; Jesse C Crow; Kyle R Miller; Stephen L Lessnick
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

5.  Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription.

Authors:  Linyu Zuo; Guanwei Zhang; Matthew Massett; Jun Cheng; Zicong Guo; Liang Wang; Yifei Gao; Ru Li; Xu Huang; Pilong Li; Zhi Qi
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

6.  Epigenetic Analysis in Ewing Sarcoma.

Authors:  Jeremy M Simon; Nicholas C Gomez
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Recent advances in the molecular pathogenesis of Ewing's sarcoma.

Authors:  E C Toomey; J D Schiffman; S L Lessnick
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

8.  Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.

Authors:  Matt L Harlow; Nichole Maloney; Joseph Roland; Maria Jose Guillen Navarro; Matthew K Easton; Susan M Kitchen-Goosen; Elissa A Boguslawski; Zachary B Madaj; Ben K Johnson; Megan J Bowman; Maurizio D'Incalci; Mary E Winn; Lisa Turner; Galen Hostetter; Carlos María Galmarini; Pablo M Aviles; Patrick J Grohar
Journal:  Cancer Res       Date:  2016-10-03       Impact factor: 12.701

Review 9.  Children's Oncology Group's 2013 blueprint for research: epidemiology.

Authors:  Logan G Spector; Julie A Ross; Andrew F Olshan
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 10.  Children's Oncology Group's 2013 blueprint for research: bone tumors.

Authors:  Richard Gorlick; Katherine Janeway; Stephen Lessnick; R Lor Randall; Neyssa Marina
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.